VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 154 filers reported holding VERASTEM INC in Q4 2021. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $21,000 | -8.7% | 15,119 | +32.4% | 0.00% | – |
| Q4 2021 | $23,000 | -47.7% | 11,419 | -20.3% | 0.00% | – |
| Q3 2021 | $44,000 | -21.4% | 14,319 | +3.6% | 0.00% | – |
| Q2 2021 | $56,000 | +93.1% | 13,819 | +17.1% | 0.00% | – |
| Q1 2021 | $29,000 | +16.0% | 11,802 | +0.2% | 0.00% | – |
| Q4 2020 | $25,000 | +78.6% | 11,780 | 0.0% | 0.00% | – |
| Q3 2020 | $14,000 | -99.2% | 11,780 | -98.9% | 0.00% | – |
| Q2 2020 | $1,810,000 | +310.4% | 1,052,180 | +219.4% | 0.00% | – |
| Q4 2019 | $441,000 | +40.9% | 329,400 | +27.5% | 0.00% | – |
| Q3 2019 | $313,000 | -19.7% | 258,300 | 0.0% | 0.00% | – |
| Q2 2019 | $390,000 | +188.9% | 258,300 | +467.3% | 0.00% | – |
| Q1 2019 | $135,000 | -11.2% | 45,528 | +0.4% | 0.00% | – |
| Q4 2018 | $152,000 | -53.7% | 45,328 | +0.3% | 0.00% | – |
| Q3 2018 | $328,000 | +49.1% | 45,211 | +41.3% | 0.00% | – |
| Q2 2018 | $220,000 | +56.0% | 31,988 | -32.4% | 0.00% | – |
| Q1 2018 | $141,000 | -57.7% | 47,300 | -56.4% | 0.00% | – |
| Q4 2017 | $333,000 | – | 108,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,865,000 | $3,823,000 | 1.61% |
| Altium Capital Management LP | 2,253,000 | $4,619,000 | 1.27% |
| BVF INC/IL | 17,062,158 | $34,977,000 | 1.27% |
| MPM BioImpact LLC | 3,271,532 | $6,707,000 | 1.22% |
| Opaleye Management Inc. | 2,325,000 | $4,766,000 | 1.01% |
| Soleus Capital Management, L.P. | 1,644,500 | $3,371,000 | 0.34% |
| Baker Brothers Advisors | 21,491,630 | $44,058,000 | 0.21% |
| Ikarian Capital, LLC | 637,371 | $1,308,000 | 0.20% |
| Samalin Investment Counsel, LLC | 90,000 | $185,000 | 0.11% |
| Parkman Healthcare Partners LLC | 183,332 | $376,000 | 0.08% |